Kazia Therapeutics studies evaluate therapeutic candidates in ovarian cancer and brain tumours
Paradigm Biopharmaceuticals to court partners and licensees for OA drug commercialisation
Medlab Clinical takes EMA and FDA approval track as cannabis research continues
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.